This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Emory University. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Innovations in Cancer Treatment by Inventor Lingtao Jin
Introduction
Lingtao Jin is an accomplished inventor based in Atlanta, GA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent developments. His work focuses on the use of glutamate dehydrogenase 1 inhibitors, which have the potential to revolutionize cancer therapies.
Latest Patents
Lingtao Jin holds a patent for "Glutamate dehydrogenase 1 inhibitors and methods of treating cancer." This patent describes methods for treating or preventing cancer by administering an effective amount of a glutamate dehydrogenase 1 inhibitor to a subject in need. The patent outlines various embodiments, including inhibitors with specific chemical formulas, such as purpurin and 2-allyl-1-hydroxyanthracene-9,10-dione, along with their prodrugs, derivatives, or salts.
Career Highlights
Lingtao Jin is affiliated with Emory University, where he conducts his research and development work. His dedication to advancing cancer treatment through innovative methods has positioned him as a notable figure in the scientific community. With a focus on practical applications of his research, he aims to improve patient outcomes in cancer therapy.
Collaborations
Lingtao Jin collaborates with esteemed colleagues, including Sumin Kang and Jing Chen. These partnerships enhance the research efforts and contribute to the development of effective cancer treatments.
Conclusion
Lingtao Jin's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His contributions through patents and collaborations highlight the importance of research in developing new therapeutic strategies.